tiprankstipranks
Theralase Technologies (TSE:TLT)
:TLT
Canadian Market

Theralase Technologies (TLT) Financial Statements

Compare
85 Followers

Theralase Technologies Financial Overview

Theralase Technologies's market cap is currently C$69.38M. The company's EPS TTM is C$-0.018; its P/E ratio is ―; Theralase Technologies is scheduled to report earnings on April 23, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total RevenueC$ 1.07MC$ 1.14MC$ 780.64KC$ 929.12KC$ 964.05K
Gross ProfitC$ 562.13KC$ 628.17KC$ 309.94KC$ 269.68KC$ 60.76K
Operating IncomeC$ -4.59MC$ -5.20MC$ -4.52MC$ -5.59MC$ -7.39M
EBITDAC$ -4.25MC$ -4.90MC$ -4.31MC$ -5.56MC$ -7.15M
Net IncomeC$ -4.57MC$ -5.25MC$ -4.42MC$ -5.61MC$ -7.43M
Balance Sheet
Cash & Short-Term InvestmentsC$ 43.91KC$ 1.51MC$ 3.69MC$ 7.88MC$ 12.55M
Total AssetsC$ 3.28MC$ 4.16MC$ 5.94MC$ 10.02MC$ 15.47M
Total DebtC$ 386.88KC$ 473.62KC$ 35.72KC$ 92.34KC$ 144.62K
Net DebtC$ 342.97KC$ -1.03MC$ -3.66MC$ -7.79MC$ -12.40M
Total LiabilitiesC$ 1.37MC$ 1.07MC$ 874.79KC$ 857.13KC$ 1.61M
Stockholders' EquityC$ 1.91MC$ 3.09MC$ 5.07MC$ 9.16MC$ 13.86M
Cash Flow
Free Cash FlowC$ -4.11MC$ -5.20MC$ -4.13MC$ -4.61MC$ -7.10M
Operating Cash FlowC$ -4.07MC$ -5.13MC$ -4.03MC$ -4.45MC$ -6.57M
Investing Cash FlowC$ -37.27KC$ -70.41KC$ -100.82KC$ -164.58KC$ -533.21K
Financing Cash FlowC$ 2.65MC$ 3.02MC$ -57.37KC$ -57.56KC$ 18.61M
Currency in CAD

Theralase Technologies Earnings and Revenue History

Theralase Technologies Debt to Assets

Theralase Technologies Cash Flow

Theralase Technologies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis